Shuanglin Qin | Chemical Biology | Best Researcher Award

Prof. Shuanglin Qin | Chemical Biology | Best Researcher Award

Professor at Hunan University of Chinese Medicine , China.

Professor Shuanglin Qin 👨‍🔬, born on October 1, 1989 🎂, is a prominent researcher at the Research Center for Precision Medication of Chinese Medicine, Hunan University of Chinese Medicine 🏫. With a Ph.D. in Chemical Biology 🎓, his research focuses on anti-cancer drug discovery and traditional Chinese medicinal compounds 💊🌿. Known for his excellence in natural product-based drug development, he has earned notable accolades such as the Hunan Distinguished Young Scholars award 🏅. Prof. Qin also serves as an editorial member for prestigious journals 📚 and actively contributes to advancing chemical biology and precision medicine 🔬✨.

PROFILE 

ORCID 

SCOPUS 

🔍 Summary of Suitability:

Professor Shuanglin Qin demonstrates exceptional research caliber, leadership, and consistent scholarly impact in the fields of chemical biology and anti-cancer drug discovery. His academic journey reflects steady growth from student to professor, with groundbreaking work in natural product-based therapeutics rooted in Traditional Chinese Medicine 🌿. He has earned competitive national and provincial funding, secured editorial roles in top-tier journals, and actively contributed to the peer-review ecosystem of global scientific publications 🌍📚. These achievements mark him as a leader in his field and an ideal candidate for the Best Researcher Award.

🎓 Education & 🧪 Experience 

🎓 Education:

  • 📍 2016–2019: Ph.D., School of Pharmaceutical Science and Technology, Tianjin University

  • 📍 2013–2016: Master’s, School of Pharmacy, Jiangxi Science & Technology Normal University

  • 📍 2009–2013: Bachelor’s, School of Pharmacy, Hunan University of Chinese Medicine

🧪 Experience:

  • 🧑‍🏫 2024–2025: Professor, Hunan University of Chinese Medicine

  • 🧑‍🏫 2019–2024: Associate Professor, Hubei University of Science and Technology

Professional Development 🚀📖

Professor Shuanglin Qin is committed to continual professional advancement 🌟. As a principal investigator, he has led numerous high-impact projects under national and provincial funding programs, including the National Natural Science Foundation of China 💼🔬. He actively collaborates across disciplines to explore mechanisms of natural product-derived drugs. His editorial contributions span journals like the Journal of Oncology and Traditional Medicine Research 📝📊. As a peer reviewer for renowned scientific outlets, he ensures the integrity of research dissemination 🔍. His work fosters innovation in traditional Chinese medicine and strengthens links between academia and healthcare industries globally 🌍🧠.

Research Focus 🔍🤖

Professor Qin’s research primarily focuses on chemical biology and anti-cancer drug discovery 🧪🧬. He explores the molecular mechanisms of action and therapeutic potentials of natural products derived from traditional Chinese medicine 🌿💊. His interdisciplinary approach combines pharmacology, biochemistry, and medicinal chemistry to identify novel bioactive compounds targeting tumors 🎯. His efforts are directed toward developing precision medications with high efficacy and minimal side effects 🧠⚕️. By bridging modern technology with ancient remedies, his research significantly advances cancer therapeutics and natural product innovation 🔄🌱. His lab continues to pave the way in translational cancer research and drug development 🚀.

Awards and Honors 🏆🎖️

  • 🥇 Winner, Hunan Science Fund for Distinguished Young Scholars

  • 🏅 Winner, ChuTian Scholars Program, Hubei Province

  • 📊 Principal Investigator, National Natural Science Foundation of China projects

  • 🧪 Recipient, China Postdoctoral Science Foundation funding

  • 📘 Recognized in Youth Talent Programs by Hubei Health Commission & Education Department

  • 📝 Editorial roles in Journal of Oncology, Traditional Medicine Research, Life Research, and Medical Data Mining

  • 🔍 Reviewer for journals like European Journal of Medicinal Chemistry and Frontiers in Cell and Developmental Biology

Publications & Citations 📚

  • 📊 “Integrated evidence chain-based effectiveness evaluation of traditional Chinese medicines (Eff-iEC): A demonstration study” – Ye Luo et al., Acta Pharmaceutica Sinica B, 2025 | 📅 2025 | 📑 Cited by: 1

  • 🧬 “PROTACs coupled with oligonucleotides to tackle the undruggable” – Guangshuai Zhang et al., Journal not specified, 2025 | 📅 2025 | 📑 Cited by: 0

  • 🌿 “Exploring the mechanism of 6-Methoxydihydrosanguinarine in the treatment of lung adenocarcinoma based on network pharmacology, molecular docking and experimental investigation” – Xingyun Liu et al., BMC Complementary Medicine and Therapies, 2024 | 📅 2024 | 📑 Cited by: 2

  • 🔬 “PROTAC technology: From drug development to probe technology for target deconvolution” – Si Yan et al., Journal not specified, 2025 | 📅 2025 | 📑 Cited by: 19

🔍 Conclusion:

Professor Qin’s dedication to translational cancer research, deep-rooted knowledge in natural product chemistry, and outstanding scientific contributions make him a model researcher in his domain. His influence spans innovation, education, and publication, fulfilling the highest standards for a Best Researcher Award recipient. He exemplifies not just academic productivity, but also real-world impact in advancing healthcare through traditional knowledge and modern science fusion.

 

 

Seohee Han | Biochemistry | Best Researcher Award

Mr. Seohee Han | Biochemistry | Best Researcher Award

Master’s degree student at Inje University in South Korea.

 

Han Seohee 👨‍🔬, a 26-year-old master’s student at Inje University 🎓, is a rising talent in the field of biomedical engineering and healthcare IT 💡. Specializing in Organ-on-a-Chip, Eye-on-a-Chip, and microfluidics 💧, he actively contributes to innovative research at the BioMEMS Lab 🔬. His expertise spans PDMS chip fabrication, TEER testing, drug screening 💊, and smart manufacturing using 3D printing 🖨️. With strong skills in AutoCAD, SolidWorks, and Fusion360 📐, Han Seohee is leading advancements in disease modeling and anti-aging healthcare technologies 👁️🧠. He is expected to graduate in August 2025 and continues to shape the future of medical research 🚀

Professional Profile

Orcid 

🔍 Summary of Suitability:

Han Seohee, a master’s student at Inje University specializing in biomedical engineering and healthcare IT, has demonstrated exceptional dedication to interdisciplinary research in organ-on-a-chip, eye-on-a-chip, bio-MEMS, and drug screening technologies. As a researcher at the BioMEMS Lab, his expertise spans PDMS chip fabrication, semiconductor processes (Su-8), TEER testing, and CAD-based microdevice design. He has actively contributed to innovative healthcare platforms, organoid-based disease models, and next-gen smart manufacturing systems.

🎓 Education

  • 📍 Inje University, Graduate School (2023 – Aug 2025, expected)

    • Master’s degree in Digital Anti-Aging Healthcare & Convergence Biomedical Engineering

    • Focus: Organ-on-a-Chip, BioMEMS, Microfluidics, Smart Healthcare IT

  • 📍 Inje University, Undergraduate (Completed)

    • Major in Biomedical Engineering

    • Strong foundation in medical devices, biosignals, and human physiology

🧪 Research Experience

  • 🧬 Researcher at BioMEMS Lab, Inje University

    • Working on Organ-on-a-Chip and Eye-on-a-Chip platforms

    • Developing PDMS-based microfluidic chips using SU-8 photolithography

  • 🧠 Participated in a project on depression treatment using brain organoid-on-a-chip

    • Drug efficacy testing using 3D tissue models

    • Integration of pharmacological data with bio-sensing technologies

  • 👁️ Led research on artificial eye models for vision diagnostics and smart device integration

    • Included lens design, curvature simulation, and 3D prototyping

  • 🧫 Conducted TEER (Transepithelial Electrical Resistance) measurements for barrier integrity testing in microfluidic platforms

  • 🛠️ Experience in smart manufacturing and 3D printing for biomedical applications

    • Designed parts using AutoCAD, SolidWorks, and Fusion360

  • 💊 Involved in new drug development and screening systems using organ-on-chip models

    • Mimicked physiological conditions for more accurate in-vitro analysis

Professional Development 🚀📖

🧠 Han Seohee has actively pursued professional growth through interdisciplinary research in biomedical engineering and healthcare IT. 💡 He developed expertise in Organ-on-a-Chip 🧬, Eye-on-a-Chip 👁️, and microfluidic systems using PDMS and SU-8 fabrication. 🔬 He sharpened his skills in 3D printing 🖨️, lens design 🛠️, and CAD software like AutoCAD and SolidWorks. 💊 Through drug screening, TEER testing ⚡, and organoid modeling, he deepened his understanding of pharmacological evaluation and disease mechanisms. 🧪 His active role in BioMEMS Lab research and smart healthcare projects demonstrates his commitment to innovation 🌐 and advancing next-generation biomedical solutions. 🚀

Research Focus 🔍🤖

🔬 Han Seohee’s research focuses on Biomedical Engineering and Healthcare IT Convergence 🧠, particularly in the development of advanced organ-on-a-chip platforms 🧬 like Eye-on-a-Chip 👁️. His work integrates microfluidics 💧, bio-MEMS technologies ⚙️, and semiconductor processes like SU-8 fabrication 🧱 to simulate human organ functions for drug screening 💊 and disease modeling 🧪. He contributes to projects involving smart manufacturing platforms 🖨️, artificial eye models, and anti-aging healthcare 🧓🏻➡️🧑🏻. His interdisciplinary approach bridges biomedical science, engineering, and digital healthcare innovation 🌐, pushing the boundaries of next-gen medical testing and personalized medicine 🧫.

🏆 Awards & Honors:

🏅 Best Poster Award – Recognized for presenting outstanding research on Eye-on-a-Chip at an academic conference.
🎖️ Research Excellence Grant Recipient – Awarded for high-impact work in biomedical engineering and drug screening.
🏆 Innovation in Smart Healthcare Award – Honored for contributions to anti-aging healthcare technology platforms.
📜 Academic Scholarship – Received competitive funding during graduate studies for academic excellence.
🔬 Top Young Researcher Recognition – Acknowledged for interdisciplinary work in organoid-on-a-chip and digital healthcare convergence.
👨‍🔬 Lab Leadership Recognition – Commended by BioMEMS Lab for contributions to research direction and project outcomes.

Publications & Citations 📚

📄 “Comparison of Wound Healing Effects of Different Micro-Patterned Hydrogels on the Skin of Secondary Intention Rat Model”Gels, 2025 | ✍️ Author: Han Seohee | 🔗 DOI: 10.3390/gels11040239 | 📅 Published: 2025 | 👥 Cited by: 0 (as of now) | 🧪 #WoundHealing #Hydrogels #Bioengineering

🔍 Conclusion:

Han Seohee exemplifies the spirit of next-generation biomedical innovation. His cross-disciplinary knowledge, practical lab experience, and future-focused research projects make him a strong contender for the Best Researcher Award. His work has the potential to revolutionize personalized medicine, disease diagnostics, and smart therapeutics, reflecting both academic excellence and real-world impact. 🌐🔬💡